Sol-Gel Technologies (NASDAQ:SLGL) & Iterum Therapeutics (NASDAQ:ITRM) Head to Head ReviewDefense World · 6 days ago
Iterum Therapeutics (NASDAQ:ITRM) vs. Scilex (NASDAQ:SCLX) Critical ReviewDefense World · Sep 28, 2026
Reviewing Iterum Therapeutics (NASDAQ:ITRM) and Ono Pharmaceutical (OTCMKTS:OPHLF)Defense World · Sep 21, 2026Iterum Therapeutics plc is a clinical-stage biopharmaceutical firm dedicated to the development and commercialization of anti-infective treatments. The company operates across Ireland, Bermuda, and the United States. Its primary therapeutic candidate is sulopenem, an innovative antimicrobial compound available in both oral and intravenous formulations.